Comprehensive evaluation of Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma
Creators
- 1. Department of Urology, Nanjing Drum Tower Hospital, Institute of Urology Nanjing University, The Affiliated Hospital of Nanjing University Medical School, Jiangsu Province (China)
- 2. Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Jiangsu (China)
- 3. Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Jiangsu (China)
Description
To evaluate parameters derived from Ga-PSMA-11 PET/CT images for discriminating pathological characteristics in primary clear-cell renal cell carcinoma (ccRCC). The study retrospectively examined data for 36 ccRCC patients with preoperative Ga-PSMA-11 PET/CT scan and surgical specimens. Radiological parameters including maximal tumor diameter, mean CT value, and maximal standard uptake value (SUV) were derived from PET/CT images. Pathological characteristics included WHO/ISUP grade and adverse pathology (tumor necrosis or sarcomatoid or rhabdoid feature). Values of radiological parameters were compared within subgroups of pathological characteristics. Receiver operating characteristic (ROC) curve analysis was used for the effectiveness of radiological parameters in differentiating pathological characteristics, estimating area under the ROC curve (AUC) and 95% confidence intervals (CIs). The WHO/ISUP grade distribution for 36 tumors was grade 1, 9 (25.0%); grade 2, 12 (33.3%); grade 3, 9 (25.0%); and grade 4, 6 (16.7%). Adverse pathology was positive for 15 (41.7%). Radiological tumor diameter and SUV significantly differed by WHO/ISUP grade, pT stage, and adverse pathology (all P < 0.05), with no difference by CT value. Tumor diameter demonstrated sensitivity 86% and specificity 88% for pT stage, with cutoff 6.70 and AUC 0.91 (95% CI, 0.79–1.00, P < 0.001). SUV could effectively differentiate WHO/ISUP grade (3–4 vs. 1–2) and adverse pathology (positive vs. negative), with AUC 0.89 (95% CI, 0.81–0.98, P < 0.001), cutoff 16.4, sensitivity 100%, and specificity 71% and AUC 0.92 (95% CI, 0.85–0.99, P < 0.001), cutoff 18.5, sensitivity 94%, and specificity 87%, respectively. Ga-PSMA-11 PET/CT could effectively identify aggressive pathological features of ccRCC.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-020-04916-6Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 48
- Journal Issue
- 2
- Journal Page Range
- p. 561-569
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 52025370
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; COMPARATIVE EVALUATIONS; DECISION MAKING; GALLIUM 68; HISTOLOGY; IMAGE PROCESSING; KIDNEYS; NECROSIS; PATHOLOGY; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY; SPECIFICITY; SURGERY; UPTAKE
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; GALLIUM ISOTOPES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANS; PATHOLOGICAL CHANGES; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; TOMOGRAPHY